Healius Ltd
OTC:PHCRF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Healius Ltd
OTC:PHCRF
|
AU |
|
B
|
Biomarin Pharmaceutical Inc
XMUN:BM8
|
US |
|
K
|
Kemper Corp
F:UI2
|
US |
|
Tsingtao Brewery Co Ltd
F:TSI
|
CN |
|
D
|
Daiwa House Industry Co Ltd
DUS:DWH
|
JP |
|
P
|
Panasonic Holdings Corp
XMUN:MAT1
|
JP |
Wall St Price Targets
PHCRF Price Targets Summary
Healius Ltd
According to Wall Street analysts, the average 1-year price target for PHCRF is 1.14 USD with a low forecast of 0.85 USD and a high forecast of 1.81 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PHCRF's stock price target?
Price Target
1.14
USD
According to Wall Street analysts, the average 1-year price target for PHCRF is 1.14 USD with a low forecast of 0.85 USD and a high forecast of 1.81 USD.
What is the Revenue forecast for Healius Ltd?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Revenue has been 0%. The projected CAGR for the next 4 years is 4%.
What is the Gross Profit forecast for Healius Ltd?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Gross Profit has been -1%. The projected CAGR for the next 4 years is 5%.
What is the Operating Income forecast for Healius Ltd?
Projected CAGR
361%
Over the last 13 years, the compound annual growth rate for Operating Income has been -42%. The projected CAGR for the next 4 years is 361%.
